LifeTech Scientific Corporation (HK:1302) has released an update.
LifeTech Scientific Corporation has announced the completion of a connected transaction involving the sale of 66,000,000 shares to fund their Share Award Scheme. The transaction saw shares sold at a discount, affecting the Seller’s interest in the company from approximately 16.42% to 14.99%. This move prompts reporting obligations under Chapter 14A of the Listing Rules, but does not require circular or independent shareholder approval.
For further insights into HK:1302 stock, check out TipRanks’ Stock Analysis page.
